1
Literature Review: Early Detection of Illness Through Screening
Student’s Name
Course
Instructor’s Name
June 6, 2024
, 2
Literature Review: Early Detection of Illness Through Screening
Early detection of illnesses through screening is a critical component of preventive
healthcare, playing a pivotal role in enhancing patient outcomes and optimizing healthcare
resources. Besides, early screening detects diseases, making treatment more accessible and
reducing mortality. These programs encompass various conditions, from common chronic
diseases such as diabetes and hypertension to life-threatening conditions like cancer
(AbdulRaheem, 2023). As a result, early illness detection boosts quality of life and lowers
healthcare costs. The literature on screening-based early detection is reviewed, gaps highlighted,
and further research suggested. Understanding screening program benefits and downsides to
enhance healthcare policies and procedures and help more people get early diagnosis and
treatment.
Article 1: Community Pharmacist-Led Point-of-Care eGFR Screening
Jairoun et al. (2024) study community pharmacist-led eGFR screening for high-risk CKD
(chronic kidney disease). This novel technique diagnoses CKD early utilizing community
pharmacists' eGFR testing. The study found that pharmacist-led exams increased early detection
and treatment. Early chronic kidney disease detection reduces healthcare expenditures, improves
patient outcomes, and prevents end-stage renal disease.
According to the study, community pharmacists can undertake these assessments because
they see high-risk patients, including diabetics and hypertensives. Patients trusting pharmacists
also boosts screening program uptake. Pharmacist-led eGFR screens are difficult to implement
due to training and resource constraints. Jairoun et al. (2024) assert that pharmacists must be
trained to test and interpret eGFR and advise patients on follow-up. Job duties involve test kits
and information systems. Despite these obstacles, the study implies that community pharmacist-
Literature Review: Early Detection of Illness Through Screening
Student’s Name
Course
Instructor’s Name
June 6, 2024
, 2
Literature Review: Early Detection of Illness Through Screening
Early detection of illnesses through screening is a critical component of preventive
healthcare, playing a pivotal role in enhancing patient outcomes and optimizing healthcare
resources. Besides, early screening detects diseases, making treatment more accessible and
reducing mortality. These programs encompass various conditions, from common chronic
diseases such as diabetes and hypertension to life-threatening conditions like cancer
(AbdulRaheem, 2023). As a result, early illness detection boosts quality of life and lowers
healthcare costs. The literature on screening-based early detection is reviewed, gaps highlighted,
and further research suggested. Understanding screening program benefits and downsides to
enhance healthcare policies and procedures and help more people get early diagnosis and
treatment.
Article 1: Community Pharmacist-Led Point-of-Care eGFR Screening
Jairoun et al. (2024) study community pharmacist-led eGFR screening for high-risk CKD
(chronic kidney disease). This novel technique diagnoses CKD early utilizing community
pharmacists' eGFR testing. The study found that pharmacist-led exams increased early detection
and treatment. Early chronic kidney disease detection reduces healthcare expenditures, improves
patient outcomes, and prevents end-stage renal disease.
According to the study, community pharmacists can undertake these assessments because
they see high-risk patients, including diabetics and hypertensives. Patients trusting pharmacists
also boosts screening program uptake. Pharmacist-led eGFR screens are difficult to implement
due to training and resource constraints. Jairoun et al. (2024) assert that pharmacists must be
trained to test and interpret eGFR and advise patients on follow-up. Job duties involve test kits
and information systems. Despite these obstacles, the study implies that community pharmacist-
